Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,467,697 papers from all fields of science
Search
Sign In
Create Free Account
Anal Canal Neuroendocrine Tumor G2
Known as:
Anal Canal NET G2
, Anal NET G2
, Anal Neuroendocrine Tumor G2
A well differentiated, intermediate grade tumor with neuroendocrine differentiation that arises from the anal canal. The mitotic count is 2-20 per 10…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Anal canal
Anus
Endocrine system
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Combination of weekly streptozocin and oral S-1 treatment for patients of unresectable or metastatic pancreatic neuroendocrine neoplasms
H. Ono
,
A. Kudo
,
+5 authors
M. Tanabe
Journal of Cancer Research and Clinical Oncology
2019
Corpus ID: 209380884
Background Streptozocin (STZ) administration with or without other cytotoxic drugs remains a crucial chemotherapy for patients…
Expand
2019
2019
Perineal hernia repair – a video vignette
Daniel R. Clerc
,
A. Kefleyesus
,
Dieter Hahnloser
Colorectal Disease
2019
Corpus ID: 58648206
Our video shows an open perineal hernia mesh repair through a Pfannenstiel incision. A fifty-seven year old woman known for a…
Expand
2017
2017
Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors
T. Iwata
,
H. Ueno
,
+9 authors
T. Okusaka
Japanese Journal of Clinical Oncology
2017
Corpus ID: 3764308
Background Detailed information regarding the clinical efficacy of radiotherapy (RT) for primary tumor in patients with…
Expand
2016
2016
Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors
Lisanne C. Hauck
,
M. Bitzer
,
N. Malek
,
R. Plentz
Scandinavian Journal of Gastroenterology
2016
Corpus ID: 24992579
Abstract Neuroendocrine tumors (NET) are malignancies with an increasing incidence rate. NETs are graded or classified by the…
Expand
2016
2016
Clinicopathological features and response to platinum-based chemotherapy in pancreatic neuroendocrine carcinoma: A retrospective multicenter study of 70 patients.
S. Hijioka
,
W. Hosoda
,
+16 authors
N. Mizuno
2016
Corpus ID: 78259073
298 Background: The WHO classified pancreatic neuroendocrine Neoplasms (pNEN) in 2010 as G1, G2, and neuroendocrine carcinoma…
Expand
2015
2015
The Role of Combined 68 Ga-DOTANOC and 18 FDG PET / CT in the Management of Patients with Pancreatic Neuroendocrine Tumors
S. Partelli
,
M. Rinzivillo
,
+5 authors
M. Falconi
2015
Corpus ID: 37808346
Purpose: The aim of this study was to evaluate the effect of combined 68 Ga and 18 F-FDG PET/CT on treatment management for…
Expand
2014
2014
The Role of Combined 68Ga-DOTANOC and 18FDG PET/CT in the Management of Patients with Pancreatic Neuroendocrine Tumors
S. Partelli
,
M. Rinzivillo
,
+5 authors
M. Falconi
Neuroendocrinology
2014
Corpus ID: 10812564
Purpose: The aim of this study was to evaluate the effect of combined <sup>68</sup>Ga and <sup>18</sup>F-FDG PET/CT on treatment…
Expand
2013
2013
The poor prognosis factors in G2 neuroendocrine tumor.
C. Poiană
,
M. C. Neamtu
,
+6 authors
R. D. Dănciulescu Miulescu
Romanian journal of morphology and embryology…
2013
Corpus ID: 3965955
BACKGROUND The G2 neuroendocrine tumors (NET) or well-differentiated neuroendocrine carcinomas (2010 WHO Classification of…
Expand
Highly Cited
2012
Highly Cited
2012
Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
Quan-Lin Li
,
Yi-Qun Zhang
,
+8 authors
P. Zhou
World Journal of Gastroenterology
2012
Corpus ID: 27062943
AIM To evaluate the feasibility and efficacy of endoscopic submucosal dissection (ESD) for foregut neuroendocrine tumors (NETs…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE